Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Biotech- and Nanotechnology
Post-Doctoral Fellowships
France
2011.04.30
Viral engineering for the treatment of neurogenic detrusor overactivity due to spinal cord injury: proof of concept study
This researcher is also supported by the Garches Foundation.
Curing bladder hyperactivity in spinal cord injured patients using gene therapy?
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Pierre
CLEMENT
Institution
Fondation Garches
Country
France
Nationality
French
Related articles
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more
Laurence
SABATIER